Specifically, we find that activated JUN in stroma is necessary and sufficient to remodel CAF-specific enhancer landscape, promotes the expression of pro-metastatic genes and thereby augments breast cancer invasiveness (Figure 6F). The gene discussed is JUN; the disease is breast carcinoma.